CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise · Restricted Stock Unit | −2,697 | 0 | ||
| 2020-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise · Restricted Stock Unit | −1,535 | 8,485 | ||
| 2020-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Other disposition · Restricted Stock Unit | −1,803 | 6,682 | ||
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise | +6,234 | 28,063.32 | ||
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −2,340 | $331.76 | $776K | 25,723.32 |
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise | +5,760 | 31,483.32 | ||
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −2,555 | $331.76 | $848K | 28,928.32 |
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −6,234 | 17,982 | ||
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −5,870 | 12,112 | ||
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,760 | 31,810 | ||
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −6,762 | 25,048 | ||
| 2020-02-12 | Vounatsos Michel Chief Executive Officer | Grant or award · Restricted Stock Unit | +37,680 | 37,680 | ||
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Option exercise | +2,211 | 12,702.25 | ||
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Shares withheld for taxes | −660 | $331.76 | $219K | 12,042.25 |
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Option exercise | +1,422 | 13,464.25 | ||
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Shares withheld for taxes | −538 | $331.76 | $178K | 12,926.25 |
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Option exercise | +1,583 | 14,509.25 | ||
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Shares withheld for taxes | −703 | $331.76 | $233K | 13,806.25 |
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Option exercise · Restricted Stock Unit | −2,211 | 0 | ||
| 2020-02-12 | Sandrock Alfred EVP, Research & Development | Option exercise · Restricted Stock Unit | −1,422 | 4,106 |
Page 46 of 61 · 1,204 trades